Abstract
Gold salts have been introduced as therapeutic agents in the late 19th century. The three gold salts approved for medical therapy auranofin, aurothiomalate, and aurothioglucose were shown to induce anti-inflammatory and immunosuppressive states via a myriad of mechanisms and used to be a mainstay of therapy for rheumatoid arthritis as well as other rheumatic and collagen vascular diseases before being supplanted by other less toxic agents. The research into the role of gold compounds in therapy of pulmonary disease have focused on asthma and demonstrated a significant anti-inflammatory effect as well as a mild steroid-sparing effect mainly in Japanese patients. These effects were offset by a wide array of adverse reactions, notably dermatological, hematological and renal effects. The main pulmonic adverse effect associated with gold therapy is interstitial pneumonitis which can present with an acute, subacute and chronic course. The role of gold salts in the therapeutic arsenal of COPD and interstitial lung diseases is less established. Recently published studies have investigated the role of aurothiomalate as an inhibitor of non-small cell lung cancer oncogene PKC iota.
Keywords: Adverse effects, asthma, gold, interstitial lung disease.
Current Respiratory Medicine Reviews
Title:Gold Salts Therapy in Respiratory Diseases
Volume: 9 Issue: 5
Author(s): Ori-Michael J. Benhamou, Maly N. Oron, Maor Waldman and Or Kalchiem-Dekel
Affiliation:
Keywords: Adverse effects, asthma, gold, interstitial lung disease.
Abstract: Gold salts have been introduced as therapeutic agents in the late 19th century. The three gold salts approved for medical therapy auranofin, aurothiomalate, and aurothioglucose were shown to induce anti-inflammatory and immunosuppressive states via a myriad of mechanisms and used to be a mainstay of therapy for rheumatoid arthritis as well as other rheumatic and collagen vascular diseases before being supplanted by other less toxic agents. The research into the role of gold compounds in therapy of pulmonary disease have focused on asthma and demonstrated a significant anti-inflammatory effect as well as a mild steroid-sparing effect mainly in Japanese patients. These effects were offset by a wide array of adverse reactions, notably dermatological, hematological and renal effects. The main pulmonic adverse effect associated with gold therapy is interstitial pneumonitis which can present with an acute, subacute and chronic course. The role of gold salts in the therapeutic arsenal of COPD and interstitial lung diseases is less established. Recently published studies have investigated the role of aurothiomalate as an inhibitor of non-small cell lung cancer oncogene PKC iota.
Export Options
About this article
Cite this article as:
Benhamou J. Ori-Michael, Oron N. Maly, Waldman Maor and Kalchiem-Dekel Or, Gold Salts Therapy in Respiratory Diseases, Current Respiratory Medicine Reviews 2013; 9 (5) . https://dx.doi.org/10.2174/1573398X10666140526234128
DOI https://dx.doi.org/10.2174/1573398X10666140526234128 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Glycoxidation and Wound Healing in Diabetes: An Interesting Relationship
Current Diabetes Reviews Selenium Compounds Biotransformed by Mushrooms: Not Only Dietary Sources, But Also Toxicity Mediators
Current Nutrition & Food Science A Review of Patents Relating to Therapeutic Angiogenesis Using Endothelial Progenitors and Other Vasculogenesis-Related Cell Types
Recent Patents on Regenerative Medicine Blood Pressure Lowering Treatment in Patients with Carotid Artery Stenosis
Current Hypertension Reviews Etanercept Improves Cognitive Performance and Increases eNOS and BDNF Expression During Experimental Vascular Dementia in Streptozotocin- induced Diabetes
Current Neurovascular Research Statin Treatment and the Natural History of Atherosclerotic-Related Diseases: Pathogenic Mechanisms and the Risk-Benefit Profile
Current Pharmaceutical Design Control of Blood Pressure in the Community: An Unsolved Problem
Current Pharmaceutical Design Patient, System and Clinician Level Interventions to Address Disparities in Diabetes Care
Current Diabetes Reviews miR-126 as a Therapeutic Agent for Diabetes Mellitus
Current Pharmaceutical Design Metabolic Syndrome as a Modifier of Atherosclerosis in Murine Models
Current Drug Targets Withdrawal Notice: Reconnoitering the Role of Endothelin in Obesity
Current Pharmaceutical Design Marine Collagen as a Source of Bioactive Molecules: A Review
The Natural Products Journal Pathophysiology of Cardiovascular Diseases and the Role of Vitamins, and Herbal Extracts in the Reduction of Cardiovascular Risks
Cardiovascular & Hematological Agents in Medicinal Chemistry Regulation of Female Fertility and Identification of Future Contraceptive Targets
Current Pharmaceutical Design Hypertension in Egypt: A Systematic Review
Current Hypertension Reviews Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) and LDL Lowering in the Contemporary Management of Dyslipidemia
Cardiovascular & Hematological Agents in Medicinal Chemistry Interactive Effect of Cigarette Smoking and Gene Variants for Predisposing to Cardiovascular Disease
Current Pharmaceutical Design Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety Molecular Interplay between Platelets and the Vascular Wall in Thrombosis and Hemostasis
Current Vascular Pharmacology The Urokinase Receptor Interactome
Current Pharmaceutical Design